References
- Fraser IS, Langham S, Uhl-Hochgraeber K. Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Rev Obstet Gynecol. 2009;4(2):179–189.
- Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss – a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966;45(3):320–351.
- Matteson KA, Clark MA. Questioning our questions: do frequently asked questions adequately cover the aspects of women’s lives most affected by abnormal uterine bleeding? Opinions of women with abnormal uterine bleeding participating in focus group discussions. Women Health. 2010;50(2):195–211.
- Santer M, Wyke S, Warner P. What aspects of periods are most bothersome for women reporting heavy menstrual bleeding? Community survey and qualitative study. BMC Womens Health. 2007;7:8.
- Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract. 2004;54(502):359–363.
- Kadir RA, Aledort LM. Obstetrical and gynaecological bleeding: a common presenting symptom. Clin Lab Haematol. 2000;22(Suppl 1): S12–S16.
- National Collaborating Centre for Women’s and Children’s Health. Heavy menstrual bleeding [homepage on the internet]. Dorchester: RCOG; 2007. Available from: http://www.nice.org.uk/nicemedia/live/11002/30401/30401.pdf. Accessed August 13, 2012.
- Coutinho EM, Segal SJ. Is Menstruation Obsolete? New York: Oxford University Press; 1999.
- Grammaticos PC, Diamantis A. Useful known and unknown views of the father of modern medicine, Hippocrates and his teacher Democritus. Hell JNucl Med. 2008;11(1):2–4.
- O’Flynn N, Britten N. Menorrhagia in general practice – disease or illness. Soc Sci Med. 2000;50(5):651–661.
- Janssen CA, Scholten PC, Heintz AP Reconsidering menorrhagia in gynecological practice. Is a 30-year-old definition still valid? Eur J Obstet Gynecol Reprod Biol. 1998;78(1):69–72.
- Santer M, Warner P, Wyke S. A Scottish postal survey suggested that the prevailing clinical preoccupation with heavy periods does not reflect the epidemiology of reported symptoms and problems. J Clin Epidemiol. 2005;58(11):1206–1210.
- Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw. 1971;78(10):933–939.
- Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding [review]. Cochrane Database Syst Rev. 2007;3:CD001017.
- Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal antiinflammatory drugs for heavy menstrual bleeding [review]. Cochrane Database Syst Rev. 2007;4:CD000400.
- Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding [review]. Cochrane Database Syst Rev. 2000;4:CD000249.
- Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding [review]. Cochrane Database Syst Rev. 2008;1:CD001016.
- Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding [review]. Cochrane Database Syst Rev. 2005;4:CD002126.
- Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol. 1991;31(1):66–70.
- Farquhar C, Brown J. Oral contraceptive pill for heavy menstrual bleeding [review]. Cochrane Database Syst Rev. 2009;4:CD000154.
- Bayer HealthCare AG. Qlaira® EU summary of product characteristics [homepage on the internet]. Available from: http://db.cbg-meb.nl/mri/spc/nlh-1230–001.pdf. Accessed August 13, 2012.
- Fraser I, Parke S, Mellinger U, Machlitt A, Serrani M, Jensen J. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care. 2011;16(4):258–269.